Investigating how androgen signaling affects prostate cancer growth and treatment.
Androgen signaling and sterol metabolism in metastatic prostate cancer: Functional and therapeutic implication
This study is looking at how certain molecules in the body affect the growth of advanced prostate cancer that doesn't respond to usual treatments, with the hope of finding new ways to help patients feel better and live longer.
Quick facts
| Grant type | R15 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cleveland State University NIH-funded |
| Lab location | 1 site (Cleveland, United States) |
| Project ID | NIH-10201013 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of androgen signaling and sterol metabolism in metastatic prostate cancer, particularly in cases that have become resistant to standard treatments. The study aims to explore how certain microRNAs can regulate key factors involved in cancer progression, specifically targeting the androgen receptor and sterol regulatory elements. By examining these molecular mechanisms, the research seeks to identify new therapeutic strategies that could improve treatment outcomes for patients with advanced prostate cancer.
Who could benefit from this research
Good fit: Ideal candidates for this research are men diagnosed with metastatic prostate cancer, particularly those whose cancer has become resistant to androgen-targeting therapies.
Not a fit: Patients with early-stage prostate cancer or those who have not undergone androgen-targeting treatments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for patients with castration-resistant prostate cancer.
How similar studies have performed: Previous research has shown promising results in targeting androgen signaling pathways in prostate cancer, indicating that this approach could be effective.
Where this research is happening
Cleveland, United States
- Cleveland State University — Cleveland, United States (Active)
Researchers
- Principal investigator: Shukla, Girish C — Cleveland State University
- Study coordinator: Shukla, Girish C
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.